P14 Therapeutic Benefit of Mepolizumab in the National Institute of Health and Care Excellence (Nice) Sub-Population– A Post-Hoc Meta-Analysis of Phase Iib/Iii Trials

doi 10.1136/thoraxjnl-2017-210983.156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and British Thoracic Society


Related search